Skip to main content
Livermore
Livermore
ZHEN

Glen Eagle Advisors, LLC

SEC CIK
0002029317
Latest filing
Aug 14, 2026

REGN holding history

Regeneron Pharmaceuticals, Inc. in every 13F filed by Glen Eagle Advisors, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

REGN overviewAll 13F holders of REGNFull Q2 2026 holdings

Shares (Q2 2026)
115
Value
$71.7K
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of REGN by Glen Eagle Advisors, LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 2026115$71.7K<0.1%+1+0.9%AddedHolders
Q1 2026114$88.1K<0.1%+37+48.1%AddedHolders
Q4 202577$59.4K<0.1%−40−34.2%ReducedHolders
Q3 2025117$65.8K<0.1%−9−7.1%ReducedHolders
Q2 2025126$66.2K<0.1%−10−7.4%ReducedHolders
Q1 2025136$86.3K<0.1%00.0%UnchangedHolders
Q4 2024136$96.9K<0.1%00.0%UnchangedHolders
Q3 2024136$143.0K<0.1%00.0%UnchangedHolders
Q2 2024136$142.9K<0.1%+10+7.9%AddedHolders
Q1 2024126$121.3K<0.1%−2−1.6%ReducedHolders
Q4 2023128$112.4K<0.1%00.0%UnchangedHolders
Q3 2023128$105.3K<0.1%00.0%UnchangedHolders
Q2 2023128$92.0K<0.1%00.0%UnchangedHolders
Q1 2023128$105.2K<0.1%−1−0.8%ReducedHolders
Q4 2022129$93.1K<0.1%+1+0.8%AddedHolders
Q3 2022128$88.2K<0.1%−8−5.9%ReducedHolders
Q2 2022136$80.4K<0.1%00.0%UnchangedHolders
Q1 2022136$95.0K<0.1%00.0%UnchangedHolders
Q4 2021136$85.9K<0.1%00.0%UnchangedHolders
Q3 2021136$82.3K<0.1%−5−3.5%ReducedHolders
Q2 2021141$78.8K<0.1%−60−29.9%ReducedHolders
Q1 2021201$95.1K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.